Our vision is to heal patients and free them from the devastating effects of osteoarthritis by restoring hyaline cartilage and reducing inflammation using our proprietary induced pluripotent stem cell (iPSC) derived hyaline cartilage cell therapy. We are developing an allogenic, off the shelf, injectable, regenerative therapy and aim to reach patients as early as possible to potentially restore joint function and prevent the need for joint replacement surgery.